AISTHESIS is building the first Sensory Intelligence platform for neurodivergent children, fusing real-time physiological and environmental signals into personalized, timely guidance, so caregivers can act before overload becomes a meltdown.
Yet it often builds before it becomes visible, while caregivers and teachers are left to recognize distress only once the child is already overwhelmed.
What is missing is a clinically relevant way to detect rising dysregulation early, identify what is driving it, and recommend the right intervention before it escalates.
1 in 6
Children experience differences in sensory processing
SPD affects an estimated 5 to 16% of children. Read more about this source
Lower school performance
Sensory processing differences are linked to worse academic outcomes
55.9%
Of parents of children with SPD report high stress levels
Children with autism, ADHD, Sensory Processing Disorder (SPD), Down syndrome, and other neurodevelopmental conditions often experience the world with heightened, or muted, sensory intensity.
Many children, especially those with developmental disorders like autism, struggle to express their sensory needs, which makes timely support difficult.
Most of a child's day happens outside formal therapy, and parents often lack the actionable insight to make that time count.
Existing low-tech solutions aren't built for how individualized SPD is. Even after diagnosis, most children still don't receive care matched to their sensory profile.
AISTHESIS works in two layers: AISTHESIS Sensory, an app every caregiver can start with today, and AISTHESIS Care, a medical device built from a wearable plus a companion app, that grows with your child's needs.
AISTHESIS Sensory is our consumer app, where every family starts, no wearable required.
Limited launch in Q1 2027. Join the waiting list or reach out to us to become a beta tester.
AISTHESIS Care is a medical device, made for families that need one: a wearable plus a companion app, working together to surface overload early and guide the response, for caregivers and the schools, hospitals and therapy centers around them.
Working toward regulatory approval, coming in 2029.
Be the first to know when we launch. Sign up and we'll notify you the moment the product is available.
Join Waiting List(opens in a new tab)Apply to become an exclusive early adopter and help shape the future of Aisthesis.
Join Beta Testing(opens in a new tab)Whether you're a school, a therapy center, a hospital, a research group, or an investor, tell us a bit about what you're looking for and we'll get back to you.
